Breaking News Instant updates and real-time market news.

SYBX

Synlogic

$3.63 /

+0.38 (+11.69%)

14:13
09/20/21
09/20
14:13
09/20/21
14:13

Synlogic phenylketonuria data 'encouraging,' says Chardan

Chardan analyst Keay Nakae says Synlogic reported "encouraging" interim clinical study data for its phenylketonuria development program. The data for SYNB1618 demonstrated that a 1e12 live cells dose was associated with a mean 20% reduction in fasting plasma phenylalanine after 14 days, which was statistically significant, with four of the eight patients having over 30% reduction in fasting phenylalanine at day 7 or day 14, Nakae tells investors in a research note. The analyst believes these interim results are encouraging but says it is important to point out that the Phase II SynPheny-1 study is open label, not randomized to a placebo control, and that the data presented thus far is from a small sample size. Nakae keeps a Buy rating on Synlogic with a $10 price target.

  • 20

    Sep

  • 16

    Apr

SYBX Synlogic
$3.63 /

+0.38 (+11.69%)

09/20/21 Piper Sandler
Synlogic price target raised to $9 at Piper Sandler on positive SynPHEny data
07/09/21 Chardan
Synlogic assumed with a Buy at Chardan
06/28/21 H.C. Wainwright
Synlogic price target lowered to $9 from $13 at H.C. Wainwright
03/25/21 SVB Leerink
Synlogic price target raised to $15 from $10 at SVB Leerink

TODAY'S FREE FLY STORIES

Hot Stocks
HSBC to launch Banking as a Service offering » 12:06
10/19/21
10/19
12:06
10/19/21
12:06
HSBC

HSBC

$29.80 /

+0.14 (+0.47%)

HSBC (HSBC) is to launch…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$29.80 /

+0.14 (+0.47%)

HSBC HSBC
$29.80 /

+0.14 (+0.47%)

10/15/21 Barclays
HSBC price target raised to 550 GBp from 530 GBp at Barclays
10/14/21 BofA
BofA upgrades HSBC to Buy, raises forecasts on recent rate moves
10/14/21 BofA
HSBC upgraded to Buy from Neutral at BofA
10/06/21 UBS
UBS upgrades HSBC to Buy, sees 'inflection point'
HSBC HSBC
$29.80 /

+0.14 (+0.47%)

HSBC HSBC
$29.80 /

+0.14 (+0.47%)

HSBC HSBC
$29.80 /

+0.14 (+0.47%)

Options
iQiyi call volume above normal and directionally bullish » 12:05
10/19/21
10/19
12:05
10/19/21
12:05
IQ

iQIYI

$9.56 /

+1.055 (+12.41%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IQ iQIYI
$9.56 /

+1.055 (+12.41%)

IQ iQIYI
$9.56 /

+1.055 (+12.41%)

10/18/21 Citi
iQIYI downgraded to Neutral from Buy at Citi
10/05/21 OTR Global
iQIYI ad business view downgraded to Mixed at OTR Global
08/13/21 KeyBanc
iQIYI price target lowered to $19 from $26 at KeyBanc
07/07/21 OTR Global
iQIYI upgraded to Positive from Mixed at OTR Global
IQ iQIYI
$9.56 /

+1.055 (+12.41%)

  • 14
    Apr
  • 17
    Dec
IQ iQIYI
$9.56 /

+1.055 (+12.41%)

IQ iQIYI
$9.56 /

+1.055 (+12.41%)

Hot Stocks
GS Acquisition Holdings Corp II stockholders approve Mirion combination » 12:02
10/19/21
10/19
12:02
10/19/21
12:02
GSAH

GS Acquisition Holdings Corp II

$10.50 /

+0.095 (+0.91%)

, MIR

Mirion

$10.39 /

+ (+0.00%)

GS Acquisition Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSAH GS Acquisition Holdings Corp II
$10.50 /

+0.095 (+0.91%)

MIR Mirion
$10.39 /

+ (+0.00%)

GSAH GS Acquisition Holdings Corp II
$10.50 /

+0.095 (+0.91%)

GSAH GS Acquisition Holdings Corp II
$10.50 /

+0.095 (+0.91%)

Hot Stocks
Silvergate Capital falls -10.9% » 12:00
10/19/21
10/19
12:00
10/19/21
12:00
SI

Silvergate Capital

$141.00 /

-17.2 (-10.87%)

Silvergate Capital is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SI Silvergate Capital
$141.00 /

-17.2 (-10.87%)

SI Silvergate Capital
$141.00 /

-17.2 (-10.87%)

10/01/21 Compass Point
Silvergate Capital transferred at Buy at Compass Point
09/27/21
Fly Intel: Top five analyst initiations
09/27/21 Morgan Stanley
Silvergate Capital initiated with an Overweight at Morgan Stanley
09/22/21 Wedbush
Silvergate Capital price target lowered to $160 from $175 at Wedbush
SI Silvergate Capital
$141.00 /

-17.2 (-10.87%)

  • 22
    Jan
SI Silvergate Capital
$141.00 /

-17.2 (-10.87%)

SI Silvergate Capital
$141.00 /

-17.2 (-10.87%)

Hot Stocks
Consol Energy falls -11.6% » 12:00
10/19/21
10/19
12:00
10/19/21
12:00
CEIX

Consol Energy

$31.60 /

-4.08 (-11.43%)

Consol Energy is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CEIX Consol Energy
$31.60 /

-4.08 (-11.43%)

CEIX Consol Energy
$31.60 /

-4.08 (-11.43%)

10/04/21 B. Riley
Consol Energy price target raised to $35 from $24 at B. Riley
05/05/21 B. Riley
Consol Energy price target raised to $14 from $12 at B. Riley
02/10/21 B. Riley Securities
Consol Energy price target raised to $11 from $8 at B. Riley Securities
Hot Stocks
Peabody Energy falls -16.4% » 12:00
10/19/21
10/19
12:00
10/19/21
12:00
BTU

Peabody Energy

$16.45 /

-3.22 (-16.37%)

Peabody Energy is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTU Peabody Energy
$16.45 /

-3.22 (-16.37%)

BTU Peabody Energy
$16.45 /

-3.22 (-16.37%)

07:54 Today B. Riley
Peabody Energy price target raised to $23 from $22 at B. Riley
10/04/21 B. Riley
Peabody Energy upgraded to Buy on rising price decks at B. Riley
10/04/21 B. Riley
Peabody Energy upgraded to Buy from Neutral at B. Riley
09/02/21 B. Riley
Peabody Energy price target raised to $15 from $11 at B. Riley
BTU Peabody Energy
$16.45 /

-3.22 (-16.37%)

BTU Peabody Energy
$16.45 /

-3.22 (-16.37%)

BTU Peabody Energy
$16.45 /

-3.22 (-16.37%)

Hot Stocks
Yirendai rises 10.8% » 12:00
10/19/21
10/19
12:00
10/19/21
12:00
YRD

Yirendai

$3.58 /

+0.35 (+10.84%)

Yirendai is up 10.8%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YRD Yirendai
$3.58 /

+0.35 (+10.84%)

Hot Stocks
Full Truck Alliance rises 13.8% » 12:00
10/19/21
10/19
12:00
10/19/21
12:00
YMM

Full Truck Alliance

$16.35 /

+1.955 (+13.58%)

Full Truck Alliance is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YMM Full Truck Alliance
$16.35 /

+1.955 (+13.58%)

YMM Full Truck Alliance
$16.35 /

+1.955 (+13.58%)

08/26/21 Citi
Full Truck Alliance initiated with Buy, $19.50 price target at Citi
08/25/21 Citi
Full Truck Alliance initiated with a Buy at Citi
08/03/21 Goldman Sachs
Full Truck Alliance initiated with a Buy at Goldman Sachs
08/02/21 China Renaissance
Full Truck Alliance initiated with a Buy at China Renaissance
  • 22
    Jun
YMM Full Truck Alliance
$16.35 /

+1.955 (+13.58%)

YMM Full Truck Alliance
$16.35 /

+1.955 (+13.58%)

General news
Treasury announced an $85 B package of 4- and 8-week bills for sale Thursday » 12:00
10/19/21
10/19
12:00
10/19/21
12:00
$ECON

Economic Data

/

+

Treasury announced an $85…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Ginkgo Bioworks rises 18.2% » 12:00
10/19/21
10/19
12:00
10/19/21
12:00
DNA

Ginkgo Bioworks

$14.45 /

+2.13 (+17.29%)

Ginkgo Bioworks is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNA Ginkgo Bioworks
$14.45 /

+2.13 (+17.29%)

DNA Ginkgo Bioworks
$14.45 /

+2.13 (+17.29%)

10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
09/20/21
Fly Intel: Top five analyst initiations
DNA Ginkgo Bioworks
$14.45 /

+2.13 (+17.29%)

DNA Ginkgo Bioworks
$14.45 /

+2.13 (+17.29%)

DNA Ginkgo Bioworks
$14.45 /

+2.13 (+17.29%)

Options
Ginkgo Bioworks Holdings Inc call volume above normal and directionally bullish » 11:45
10/19/21
10/19
11:45
10/19/21
11:45
DNA

Ginkgo Bioworks

$14.02 /

+1.7 (+13.80%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DNA Ginkgo Bioworks
$14.02 /

+1.7 (+13.80%)

DNA Ginkgo Bioworks
$14.02 /

+1.7 (+13.80%)

10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
09/20/21
Fly Intel: Top five analyst initiations
DNA Ginkgo Bioworks
$14.02 /

+1.7 (+13.80%)

DNA Ginkgo Bioworks
$14.02 /

+1.7 (+13.80%)

DNA Ginkgo Bioworks
$14.02 /

+1.7 (+13.80%)

Recommendations
Morgan Stanley keeps $900 target on Tesla, sees 'pretty good' Q3 results » 11:43
10/19/21
10/19
11:43
10/19/21
11:43
TSLA

Tesla

$869.07 /

-1.19 (-0.14%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$869.07 /

-1.19 (-0.14%)

TSLA Tesla
$869.07 /

-1.19 (-0.14%)

10/18/21 Wedbush
Wedbush expects another 'robust' quarter from Tesla
10/18/21 Bernstein
Bernstein still 'struggles' with Tesla stock valuation
10/15/21 Jefferies
Tesla price target raised to $950 from $850 at Jefferies
10/14/21 Barclays
Tesla price target raised to $300 from $230 at Barclays
TSLA Tesla
$869.07 /

-1.19 (-0.14%)

TSLA Tesla
$869.07 /

-1.19 (-0.14%)

TSLA Tesla
$869.07 /

-1.19 (-0.14%)

TSLA Tesla
$869.07 /

-1.19 (-0.14%)

Hot Stocks
Vivos, Candid collaborate for sleep apnea, orthodontic treatment solution » 11:32
10/19/21
10/19
11:32
10/19/21
11:32
VVOS

Vivos Therapeutics

$3.92 /

+0.02 (+0.51%)

Vivos Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VVOS Vivos Therapeutics
$3.92 /

+0.02 (+0.51%)

VVOS Vivos Therapeutics
$3.92 /

+0.02 (+0.51%)

01/11/21 Craig-Hallum
Craig-Hallum bullish on Vivos Therapeutics, initiates with a Buy
01/11/21 Craig-Hallum
Vivos Therapeutics initiated with a Buy at Craig-Hallum
01/05/21 Roth Capital
Vivos Therapeutics initiated with a Buy at Roth Capital
VVOS Vivos Therapeutics
$3.92 /

+0.02 (+0.51%)

  • 11
    Dec
VVOS Vivos Therapeutics
$3.92 /

+0.02 (+0.51%)

Hot Stocks
Penn National completes acquisition of Score Media » 11:28
10/19/21
10/19
11:28
10/19/21
11:28
PENN

Penn National

$79.72 /

+2.41 (+3.12%)

, SCR

Score Media

$35.54 /

+ (+0.00%)

Penn National Gaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PENN Penn National
$79.72 /

+2.41 (+3.12%)

SCR Score Media
$35.54 /

+ (+0.00%)

PENN Penn National
$79.72 /

+2.41 (+3.12%)

09:54 Today
Fly Intel: Top five analyst initiations
06:29 Today Berenberg
Berenberg starts Penn National at Buy with $95 price target
06:08 Today Berenberg
Penn National initiated with a Buy at Berenberg
10/15/21 JPMorgan
Penn National valuation 'undemanding' after underperformance, says JPMorgan
SCR Score Media
$35.54 /

+ (+0.00%)

09/09/21 Macquarie
Score Media downgraded to Neutral from Outperform at Macquarie
08/05/21 Stifel
Stifel positive on Penn National's acquisition of theScore
06/30/21
Fly Intel: Top five analyst initiations
06/30/21 Morgan Stanley
Score Media initiated with an Equal Weight at Morgan Stanley
PENN Penn National
$79.72 /

+2.41 (+3.12%)

  • 25
    Feb
PENN Penn National
$79.72 /

+2.41 (+3.12%)

SCR Score Media
$35.54 /

+ (+0.00%)

PENN Penn National
$79.72 /

+2.41 (+3.12%)

SCR Score Media
$35.54 /

+ (+0.00%)

PENN Penn National
$79.72 /

+2.41 (+3.12%)

SCR Score Media
$35.54 /

+ (+0.00%)

Options
Sweep Call Buyer lays out $560k in Fastly Inc » 11:27
10/19/21
10/19
11:27
10/19/21
11:27
FSLY

Fastly

$47.14 /

+2.365 (+5.28%)

Sweep Call Buyer lays out…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$47.14 /

+2.365 (+5.28%)

FSLY Fastly
$47.14 /

+2.365 (+5.28%)

09/08/21 Evercore ISI
Evercore says Akamai, Cloudflare, Fastly may partner with Apple on new service
08/09/21 Raymond James
Fastly reinstated with a Market Perform at Raymond James
08/05/21
Fly Intel: Top five analyst downgrades
08/05/21 Craig-Hallum
Fastly price target lowered to $42 from $55 at Craig-Hallum
FSLY Fastly
$47.14 /

+2.365 (+5.28%)

FSLY Fastly
$47.14 /

+2.365 (+5.28%)

FSLY Fastly
$47.14 /

+2.365 (+5.28%)

FSLY Fastly
$47.14 /

+2.365 (+5.28%)

Options
Paysafe Ltd call volume above normal and directionally bullish » 11:25
10/19/21
10/19
11:25
10/19/21
11:25
PSFE

Paysafe

$8.13 /

+0.43 (+5.58%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSFE Paysafe
$8.13 /

+0.43 (+5.58%)

PSFE Paysafe
$8.13 /

+0.43 (+5.58%)

08/17/21 Compass Point
Paysafe price target lowered to $13 from $19 at Compass Point
08/12/21 BofA
Paysafe started with a Buy at BofA amid rapidly growing iGaming market
08/12/21 BofA
Paysafe initiated with a Buy at BofA
06/28/21 Cowen
Paysafe initiated with an Outperform at Cowen
PSFE Paysafe
$8.13 /

+0.43 (+5.58%)

PSFE Paysafe
$8.13 /

+0.43 (+5.58%)

PSFE Paysafe
$8.13 /

+0.43 (+5.58%)

Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call » 11:25
10/19/21
10/19
11:25
10/19/21
11:25
SNY

Sanofi

$47.87 /

-0.165 (-0.34%)

, FOLD

Amicus

$10.91 /

+0.21 (+1.96%)

, ABEO

Abeona Therapeutics

/

+

, QURE

uniQure

$28.57 /

+0.26 (+0.92%)

, SIOX

Sio Gene Therapies

$2.20 /

+0.02 (+0.92%)

, TSHA

Taysha Gene Therapies

$17.85 /

+0.77 (+4.51%)

, SELB

Selecta Biosciences

$4.06 /

-0.05 (-1.22%)

, DNLI

Denali Therapeutics

$45.89 /

+0.725 (+1.61%)

, ORTX

Orchard Therapeutics

$2.07 /

-0.045 (-2.13%)

Biotech Analysts Duncan,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.87 /

-0.165 (-0.34%)

FOLD Amicus
$10.91 /

+0.21 (+1.96%)

ABEO Abeona Therapeutics
/

+

QURE uniQure
$28.57 /

+0.26 (+0.92%)

SIOX Sio Gene Therapies
$2.20 /

+0.02 (+0.92%)

TSHA Taysha Gene Therapies
$17.85 /

+0.77 (+4.51%)

SELB Selecta Biosciences
$4.06 /

-0.05 (-1.22%)

DNLI Denali Therapeutics
$45.89 /

+0.725 (+1.61%)

ORTX Orchard Therapeutics
$2.07 /

-0.045 (-2.13%)

SNY Sanofi
$47.87 /

-0.165 (-0.34%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
FOLD Amicus
$10.91 /

+0.21 (+1.96%)

09/30/21
Fly Intel: Top five analyst upgrades
09/30/21 Cowen
Amicus spin-out and profit potential makes it takeout target, says Cowen
09/30/21 JPMorgan
Amicus upgraded to Overweight from Neutral at JPMorgan
07/19/21 BTIG
Amicus assumed with a Buy at BTIG
ABEO Abeona Therapeutics
/

+

07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
11/25/20 H.C. Wainwright
Abeona Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
11/11/20 B. Riley Securities
Abeona Therapeutics price target raised to $3 from $2 at B. Riley Securities
11/10/20 Cantor Fitzgerald
Cantor upgrades Abeona to Overweight with shares trading near cash
QURE uniQure
$28.57 /

+0.26 (+0.92%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
SIOX Sio Gene Therapies
$2.20 /

+0.02 (+0.92%)

07/09/21 Chardan
Sio Gene Therapies coverage transferred at Chardan
06/14/21 BTIG
Sio Gene Therapies initiated with a Buy at BTIG
04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
TSHA Taysha Gene Therapies
$17.85 /

+0.77 (+4.51%)

08:44 Today Morgan Stanley
Taysha Gene Therapies assumed with an Overweight at Morgan Stanley
10/05/21 Needham
Taysha Gene Therapies price target raised to $47 from $45 at Needham
08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
SELB Selecta Biosciences
$4.06 /

-0.05 (-1.22%)

07/22/21 Cantor Fitzgerald
Incorrect headline could be cause of Selecta weakness, says Cantor Fitzgerald
06/14/21 BTIG
Selecta Biosciences initiated with a Buy at BTIG
04/29/21 Mizuho
Mizuho sees 'minimal impact' to Selecta Biosciences from AskBio assumption news
03/12/21 William Blair
Selecta upgraded to Outperform ahead of catalysts at William Blair
DNLI Denali Therapeutics
$45.89 /

+0.725 (+1.61%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/01/21 SMBC Nikko
Denali Therapeutics initiated with an Outperform at SMBC Nikko
07/26/21 Stifel
Denali DNL310 data 'noisy and trending in wrong direction,' says Stifel
07/26/21 H.C. Wainwright
Denali Therapeutics price target raised to $105 from $95 at H.C. Wainwright
ORTX Orchard Therapeutics
$2.07 /

-0.045 (-2.13%)

08/18/21 JPMorgan
Orchard Therapeutics downgraded to Neutral from Overweight at JPMorgan
07/02/21 Wedbush
Pharming collaboration offers upside for Orchard Therapeutics, says Wedbush
06/30/21 JPMorgan
Orchard Therapeutics price target lowered to $14 from $15 at JPMorgan
06/30/21 Cantor Fitzgerald
Orchard Therapeutics price target lowered to $12 from $17 at Cantor Fitzgerald
SNY Sanofi
$47.87 /

-0.165 (-0.34%)

FOLD Amicus
$10.91 /

+0.21 (+1.96%)

ABEO Abeona Therapeutics
/

+

QURE uniQure
$28.57 /

+0.26 (+0.92%)

SIOX Sio Gene Therapies
$2.20 /

+0.02 (+0.92%)

TSHA Taysha Gene Therapies
$17.85 /

+0.77 (+4.51%)

SELB Selecta Biosciences
$4.06 /

-0.05 (-1.22%)

DNLI Denali Therapeutics
$45.89 /

+0.725 (+1.61%)

ORTX Orchard Therapeutics
$2.07 /

-0.045 (-2.13%)

SNY Sanofi
$47.87 /

-0.165 (-0.34%)

ORTX Orchard Therapeutics
$2.07 /

-0.045 (-2.13%)

SNY Sanofi
$47.87 /

-0.165 (-0.34%)

FOLD Amicus
$10.91 /

+0.21 (+1.96%)

QURE uniQure
$28.57 /

+0.26 (+0.92%)

TSHA Taysha Gene Therapies
$17.85 /

+0.77 (+4.51%)

DNLI Denali Therapeutics
$45.89 /

+0.725 (+1.61%)

Recommendations
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature' » 11:23
10/19/21
10/19
11:23
10/19/21
11:23
AVIR

Atea Pharmaceuticals

$15.80 /

-24.75 (-61.04%)

, RHHBY

Roche

$49.16 /

+0.24 (+0.49%)

William Blair analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVIR Atea Pharmaceuticals
$15.80 /

-24.75 (-61.04%)

RHHBY Roche
$49.16 /

+0.24 (+0.49%)

AVIR Atea Pharmaceuticals
$15.80 /

-24.75 (-61.04%)

08:19 Today Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/18/21 JPMorgan
Atea Pharmaceuticals price target raised to $61 from $56 at JPMorgan
10/05/21 Morgan Stanley
Atea downgraded to Equal Weight at Morgan Stanley following molnupiravir rally
10/05/21 Morgan Stanley
Atea downgraded to Equal Weight from Overweight at Morgan Stanley
RHHBY Roche
$49.16 /

+0.24 (+0.49%)

10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
RHHBY Roche
$49.16 /

+0.24 (+0.49%)

  • 30
    Oct
AVIR Atea Pharmaceuticals
$15.80 /

-24.75 (-61.04%)

RHHBY Roche
$49.16 /

+0.24 (+0.49%)

AVIR Atea Pharmaceuticals
$15.80 /

-24.75 (-61.04%)

RHHBY Roche
$49.16 /

+0.24 (+0.49%)

Syndicate
Fintech Ecosystem Development opens at $10.05, IPO priced at $10 » 11:22
10/19/21
10/19
11:22
10/19/21
11:22
FEXD

Fintech Ecosystem Development

/

+

Fintech Ecosystem…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
SVB Leerink biotechnology analysts to hold analyst/industry conference call » 11:20
10/19/21
10/19
11:20
10/19/21
11:20

Biotechnology Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Blockchain Moon Acquisition opens at $10.10, IPO priced at $10 » 11:19
10/19/21
10/19
11:19
10/19/21
11:19
BMAQ

Blockchain Moon Acquisition

/

+

Blockchain Moon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 11:17
10/19/21
10/19
11:17
10/19/21
11:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 11:16
10/19/21
10/19
11:16
10/19/21
11:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Earnings
Notable companies reporting before tomorrow's open » 11:15
10/19/21
10/19
11:15
10/19/21
11:15
VZ

Verizon

$52.03 /

+0.11 (+0.21%)

, ABT

Abbott

$118.60 /

+1.775 (+1.52%)

, BIIB

Biogen

$270.23 /

+0.32 (+0.12%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Verizon Communications (VZ), consensus $1.36... Abbott Laboratories (ABT), consensus 94c... Biogen (BIIB), consensus $4.11.

ShowHide Related Items >><<
VZ Verizon
$52.03 /

+0.11 (+0.21%)

ABT Abbott
$118.60 /

+1.775 (+1.52%)

BIIB Biogen
$270.23 /

+0.32 (+0.12%)

VZ Verizon
$52.03 /

+0.11 (+0.21%)

06:48 Today Deutsche Bank
Verizon resumed with a Hold at Deutsche Bank
10/13/21 Morgan Stanley
Morgan Stanley says Comcast dropping network a modest near-term negative for MSG
09/20/21 Loop Capital
Verizon initiated with a Hold, $57 target at Loop Capital
09/20/21 Loop Capital
Verizon initiated with a Hold at Loop Capital
ABT Abbott
$118.60 /

+1.775 (+1.52%)

10/14/21 Redburn
Abbott initiated with a Neutral at Redburn
10/04/21 Cowen
Abbott Q3 results not likely to contain sales warning, says at Cowen
10/01/21 Citi
Abbott price target raised to $140 from $135 at Citi
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
BIIB Biogen
$270.23 /

+0.32 (+0.12%)

10/17/21 Piper Sandler
Piper Sandler remains bullish on Biogen despite mixed VALOR study update
10/15/21 Cantor Fitzgerald
Biogen price target lowered to $327 from $427 at Cantor Fitzgerald
10/15/21 Stifel
Biogen price target lowered to $344 from $430 at Stifel
10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
VZ Verizon
$52.03 /

+0.11 (+0.21%)

ABT Abbott
$118.60 /

+1.775 (+1.52%)

BIIB Biogen
$270.23 /

+0.32 (+0.12%)

VZ Verizon
$52.03 /

+0.11 (+0.21%)

ABT Abbott
$118.60 /

+1.775 (+1.52%)

BIIB Biogen
$270.23 /

+0.32 (+0.12%)

VZ Verizon
$52.03 /

+0.11 (+0.21%)

ABT Abbott
$118.60 /

+1.775 (+1.52%)

BIIB Biogen
$270.23 /

+0.32 (+0.12%)

VZ Verizon
$52.03 /

+0.11 (+0.21%)

ABT Abbott
$118.60 /

+1.775 (+1.52%)

BIIB Biogen
$270.23 /

+0.32 (+0.12%)

Conference/Events
Alphabet Class A to hold a virtual launch event » 11:14
10/19/21
10/19
11:14
10/19/21
11:14
GOOGL

Alphabet Class A

$2,859.40 /

+4.67 (+0.16%)

Launch event for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOGL Alphabet Class A
$2,859.40 /

+4.67 (+0.16%)

GOOGL Alphabet Class A
$2,859.40 /

+4.67 (+0.16%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Credit Suisse remains bullish on Alphabet ahead of quarterly results
10/12/21 JPMorgan
JPMorgan says Alphabet 'clearly the most liked' mega-cap internet stock
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
GOOGL Alphabet Class A
$2,859.40 /

+4.67 (+0.16%)

GOOGL Alphabet Class A
$2,859.40 /

+4.67 (+0.16%)

GOOGL Alphabet Class A
$2,859.40 /

+4.67 (+0.16%)

GOOGL Alphabet Class A
$2,859.40 /

+4.67 (+0.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.